FDA Approves Chemo-Free Combo for Lung Cancer FDA Approves Chemo-Free Combo for Lung Cancer
The combination of nivolumab plus ipilimumab is now approved as first-line treatment for patients with metastatic non-small-cell lung cancer.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Lung Cancer | Non-Small Cell Lung Cancer | Yervoy